Clinical Manifestations

Patients with Primary Progressive Aphasias (PPAs) almost systematically inquire about the longitudinal evolution of their disease in clinics but very little research exists on the issue. We studied 82 PPA patients from the Research Chair on PPA - Fondation de la Famille Lemaire Cohort over a 10-year...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alzheimer's & dementia 2024-12, Vol.20 Suppl 3, p.e088276
Hauptverfasser: Tastevin, Maud, Lavoie, Monica, Laforce, Jr, Robert
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page e088276
container_title Alzheimer's & dementia
container_volume 20 Suppl 3
creator Tastevin, Maud
Lavoie, Monica
Laforce, Jr, Robert
description Patients with Primary Progressive Aphasias (PPAs) almost systematically inquire about the longitudinal evolution of their disease in clinics but very little research exists on the issue. We studied 82 PPA patients from the Research Chair on PPA - Fondation de la Famille Lemaire Cohort over a 10-year span (42 logopenic, 21 non-fluent/agrammatic and 19 semantic PPAs) and collected data from 5 domains (language, cognition, motor, psychiatric, functional) at 5 time points from onset to death. Logistical regression analyses and repeated measures ANOVAs were conducted to delineate the longitudinal profile of each variant PPA. All patients presented anomia and executive impairments over time. Language deficits tended to be more significant for lvPPA, particularly after 3 years of evolution and this group showed broader cognitive impairments. Psychiatric symptoms were more frequent in svPPA and nfvPPA, particularly after 5 years of evolution. Motor features predominantly affected patients with nfvPPA after 2 years of evolution. Overall functional abilities remained preserved the longest in svPPA (up to 5 years). To our knowledge, this naturalistic study on all major PPA symptoms over a 10-year span from onset to death is the largest to date. Data from this study can help clinicians better inform and prepare their patients for future challenges as well as design more focused interventions.
doi_str_mv 10.1002/alz.088276
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_3151203426</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3151203426</sourcerecordid><originalsourceid>FETCH-LOGICAL-p560-3a52089b172b638d1f2b1a19d4bf987844fd0f7733420f4944ecfb454295ba003</originalsourceid><addsrcrecordid>eNpNj7tLBDEYxIMo3kMbGzuxtNnz-_JOKcupByc21y_JbgKR7MPNbaF_vQueYDVT_GaGIeQGYYMA9NGm7w1oTZU8I0sUghaCKnP-zy_IKucPAA4axSVZMKMESIQluS1T7GJt0_2b7WLw-WiPse_yFbkINmV_fdI1OTxvD-VrsX9_2ZVP-2IQEgpmBQVtHCrqJNMNBurQomm4C0YrzXloICjFGKcQuOHc18FxwakRzgKwNXn4rR3G_nOa16s25tqnZDvfT7liKJDCnJYzendCJ9f6phrG2Nrxq_r7wn4ARn1Hmw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3151203426</pqid></control><display><type>article</type><title>Clinical Manifestations</title><source>MEDLINE</source><source>PubMed Central Open Access</source><source>Wiley-Blackwell Open Access Titles</source><source>Wiley Online Library All Journals</source><source>PubMed Central</source><creator>Tastevin, Maud ; Lavoie, Monica ; Laforce, Jr, Robert</creator><creatorcontrib>Tastevin, Maud ; Lavoie, Monica ; Laforce, Jr, Robert</creatorcontrib><description>Patients with Primary Progressive Aphasias (PPAs) almost systematically inquire about the longitudinal evolution of their disease in clinics but very little research exists on the issue. We studied 82 PPA patients from the Research Chair on PPA - Fondation de la Famille Lemaire Cohort over a 10-year span (42 logopenic, 21 non-fluent/agrammatic and 19 semantic PPAs) and collected data from 5 domains (language, cognition, motor, psychiatric, functional) at 5 time points from onset to death. Logistical regression analyses and repeated measures ANOVAs were conducted to delineate the longitudinal profile of each variant PPA. All patients presented anomia and executive impairments over time. Language deficits tended to be more significant for lvPPA, particularly after 3 years of evolution and this group showed broader cognitive impairments. Psychiatric symptoms were more frequent in svPPA and nfvPPA, particularly after 5 years of evolution. Motor features predominantly affected patients with nfvPPA after 2 years of evolution. Overall functional abilities remained preserved the longest in svPPA (up to 5 years). To our knowledge, this naturalistic study on all major PPA symptoms over a 10-year span from onset to death is the largest to date. Data from this study can help clinicians better inform and prepare their patients for future challenges as well as design more focused interventions.</description><identifier>ISSN: 1552-5279</identifier><identifier>EISSN: 1552-5279</identifier><identifier>DOI: 10.1002/alz.088276</identifier><identifier>PMID: 39750610</identifier><language>eng</language><publisher>United States</publisher><subject>Aged ; Aphasia, Primary Progressive ; Disease Progression ; Executive Function - physiology ; Female ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Neuropsychological Tests - statistics &amp; numerical data</subject><ispartof>Alzheimer's &amp; dementia, 2024-12, Vol.20 Suppl 3, p.e088276</ispartof><rights>2024 The Alzheimer's Association. Alzheimer's &amp; Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39750610$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tastevin, Maud</creatorcontrib><creatorcontrib>Lavoie, Monica</creatorcontrib><creatorcontrib>Laforce, Jr, Robert</creatorcontrib><title>Clinical Manifestations</title><title>Alzheimer's &amp; dementia</title><addtitle>Alzheimers Dement</addtitle><description>Patients with Primary Progressive Aphasias (PPAs) almost systematically inquire about the longitudinal evolution of their disease in clinics but very little research exists on the issue. We studied 82 PPA patients from the Research Chair on PPA - Fondation de la Famille Lemaire Cohort over a 10-year span (42 logopenic, 21 non-fluent/agrammatic and 19 semantic PPAs) and collected data from 5 domains (language, cognition, motor, psychiatric, functional) at 5 time points from onset to death. Logistical regression analyses and repeated measures ANOVAs were conducted to delineate the longitudinal profile of each variant PPA. All patients presented anomia and executive impairments over time. Language deficits tended to be more significant for lvPPA, particularly after 3 years of evolution and this group showed broader cognitive impairments. Psychiatric symptoms were more frequent in svPPA and nfvPPA, particularly after 5 years of evolution. Motor features predominantly affected patients with nfvPPA after 2 years of evolution. Overall functional abilities remained preserved the longest in svPPA (up to 5 years). To our knowledge, this naturalistic study on all major PPA symptoms over a 10-year span from onset to death is the largest to date. Data from this study can help clinicians better inform and prepare their patients for future challenges as well as design more focused interventions.</description><subject>Aged</subject><subject>Aphasia, Primary Progressive</subject><subject>Disease Progression</subject><subject>Executive Function - physiology</subject><subject>Female</subject><subject>Humans</subject><subject>Longitudinal Studies</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neuropsychological Tests - statistics &amp; numerical data</subject><issn>1552-5279</issn><issn>1552-5279</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNj7tLBDEYxIMo3kMbGzuxtNnz-_JOKcupByc21y_JbgKR7MPNbaF_vQueYDVT_GaGIeQGYYMA9NGm7w1oTZU8I0sUghaCKnP-zy_IKucPAA4axSVZMKMESIQluS1T7GJt0_2b7WLw-WiPse_yFbkINmV_fdI1OTxvD-VrsX9_2ZVP-2IQEgpmBQVtHCrqJNMNBurQomm4C0YrzXloICjFGKcQuOHc18FxwakRzgKwNXn4rR3G_nOa16s25tqnZDvfT7liKJDCnJYzendCJ9f6phrG2Nrxq_r7wn4ARn1Hmw</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Tastevin, Maud</creator><creator>Lavoie, Monica</creator><creator>Laforce, Jr, Robert</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>202412</creationdate><title>Clinical Manifestations</title><author>Tastevin, Maud ; Lavoie, Monica ; Laforce, Jr, Robert</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p560-3a52089b172b638d1f2b1a19d4bf987844fd0f7733420f4944ecfb454295ba003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Aged</topic><topic>Aphasia, Primary Progressive</topic><topic>Disease Progression</topic><topic>Executive Function - physiology</topic><topic>Female</topic><topic>Humans</topic><topic>Longitudinal Studies</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neuropsychological Tests - statistics &amp; numerical data</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tastevin, Maud</creatorcontrib><creatorcontrib>Lavoie, Monica</creatorcontrib><creatorcontrib>Laforce, Jr, Robert</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Alzheimer's &amp; dementia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tastevin, Maud</au><au>Lavoie, Monica</au><au>Laforce, Jr, Robert</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical Manifestations</atitle><jtitle>Alzheimer's &amp; dementia</jtitle><addtitle>Alzheimers Dement</addtitle><date>2024-12</date><risdate>2024</risdate><volume>20 Suppl 3</volume><spage>e088276</spage><pages>e088276-</pages><issn>1552-5279</issn><eissn>1552-5279</eissn><abstract>Patients with Primary Progressive Aphasias (PPAs) almost systematically inquire about the longitudinal evolution of their disease in clinics but very little research exists on the issue. We studied 82 PPA patients from the Research Chair on PPA - Fondation de la Famille Lemaire Cohort over a 10-year span (42 logopenic, 21 non-fluent/agrammatic and 19 semantic PPAs) and collected data from 5 domains (language, cognition, motor, psychiatric, functional) at 5 time points from onset to death. Logistical regression analyses and repeated measures ANOVAs were conducted to delineate the longitudinal profile of each variant PPA. All patients presented anomia and executive impairments over time. Language deficits tended to be more significant for lvPPA, particularly after 3 years of evolution and this group showed broader cognitive impairments. Psychiatric symptoms were more frequent in svPPA and nfvPPA, particularly after 5 years of evolution. Motor features predominantly affected patients with nfvPPA after 2 years of evolution. Overall functional abilities remained preserved the longest in svPPA (up to 5 years). To our knowledge, this naturalistic study on all major PPA symptoms over a 10-year span from onset to death is the largest to date. Data from this study can help clinicians better inform and prepare their patients for future challenges as well as design more focused interventions.</abstract><cop>United States</cop><pmid>39750610</pmid><doi>10.1002/alz.088276</doi></addata></record>
fulltext fulltext
identifier ISSN: 1552-5279
ispartof Alzheimer's & dementia, 2024-12, Vol.20 Suppl 3, p.e088276
issn 1552-5279
1552-5279
language eng
recordid cdi_proquest_miscellaneous_3151203426
source MEDLINE; PubMed Central Open Access; Wiley-Blackwell Open Access Titles; Wiley Online Library All Journals; PubMed Central
subjects Aged
Aphasia, Primary Progressive
Disease Progression
Executive Function - physiology
Female
Humans
Longitudinal Studies
Male
Middle Aged
Neuropsychological Tests - statistics & numerical data
title Clinical Manifestations
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T14%3A08%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20Manifestations&rft.jtitle=Alzheimer's%20&%20dementia&rft.au=Tastevin,%20Maud&rft.date=2024-12&rft.volume=20%20Suppl%203&rft.spage=e088276&rft.pages=e088276-&rft.issn=1552-5279&rft.eissn=1552-5279&rft_id=info:doi/10.1002/alz.088276&rft_dat=%3Cproquest_pubme%3E3151203426%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3151203426&rft_id=info:pmid/39750610&rfr_iscdi=true